- April 18, 2019
Startup launches to tackle cough, itch, pain
Based on innovations from Harvard University and Boston Children's Hospital, Nocion Therapeutics aims to selectively silence pain and itch neurons
- March 26, 2019
Harvard researchers’ immune-silent stem cell technology licensed to Sana Biotechnology
Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease
- February 11, 2019
A bioengineered factory for T-cells
Injectable sponge-like gel enhances the quantity and quality of T-cells
- February 08, 2019
Toward safer bone-marrow transplants
New advances selectively suppress damaged cells, allowing for transplants without chemotherapy or radiation
- February 07, 2019
The science and business of aging
FUSION symposium brings two spheres together to lend insights to action
Tag: Blavatnik